[Screening for cerebral arteriovenous malformations in patients with hereditary haemorrhagic telangiectasia].
Ugeskr Laeger
; 183(20)2021 05 17.
Article
in Da
| MEDLINE
| ID: mdl-33998447
ABSTRACT
Patients with hereditary haemorrhagic telangiectasia (HHT) are known to suffer from cerebral arteriovenous malformations (CAVMs). In this review, we explore existing literature for bleeding risk, interventional therapy and neuroradiological features in HHT-related CAVMs. Studies estimate the annual intracerebral haemorrhage rate of CAVMs in HHT patients to be 0.667-1.014%. The clinician must balance bleeding risk and the non-negligible procedural risks of interventional therapy. We recommend, in agreement with European guidelines, that screening of asymptomatic HHT patients should only be carried out after careful information.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Telangiectasia, Hereditary Hemorrhagic
/
Intracranial Arteriovenous Malformations
Type of study:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
/
Screening_studies
Limits:
Humans
Language:
Da
Journal:
Ugeskr Laeger
Year:
2021
Document type:
Article